Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway

Mengmeng Zhu, Qiong Zhang, Xiaoling Wang, Licheng Kang, Yinan Yang, Yuansheng Liu, Lei Yang, Jing Li, Liang Yang, Jie Liu,

Oncotarget · 2016 · 35 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

// Mengmeng Zhu 1, * , Qiong Zhang 2, * , Xiaoling Wang 1 , Licheng Kang 1 , Yinan Yang 1 , Yuansheng Liu 1 , Lei Yang 3 , Jing Li 1 , Liang Yang 1 , Jie Liu 1 , Yin Li 4 , Lingling Zu 5 , Yanna Shen 2 , Zhi Qi 1 1 Department of Histology and Embryology, School of Medicine, Nankai University, Tianjin, China 2 Department of Microbiology, School of Laboratory Medicine, Tianjin Medical University, Tianjin, China 3 Tianjin Institute of Acute Abdominal Diseases of Integrated Traditional Chinese and Western Medicine, Tianjin Nankai Hospital, Tianjin, China 4 Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China 5 Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenviroment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China * These authors contributed equally to this work Correspondence to: Yanna Shen, email: shenyanna@sina.com Zhi Qi, email: qizhi@nankai.edu.cn Keywords: pancreatic cancer, metformin, resveratrol, VEGF-B, apoptosis Received: February 28, 2016      Accepted: September 25, 2016      Published: October 01, 2016 ABSTRACT Our previous study showed that resveratrol (RSV) exhibited not only anti-tumor effect, but also had potential tumor promotion effect on pancreatic cancer (Paca) cells through up-regulation of VEGF-B. We determined whether metformin (MET) could potentiate the anti-tumor effect of RSV on PaCa in this study. Combination of RSV (100 μmol/l) and MET (20 mmol/l) significantly inhibited tumor growth and increased apoptosis of human PaCa in comparison with RSV or MET alone treatment in PaCa cell lines (Miapaca-2, Panc-1 and Capan-2). Combination of RSV (60 mg/kg, gavage) and MET (250 mg/kg, i.p.) significantly inhibited tumor growth in PaCa bearing nude mice (subcutaneous injection of 5 × 10 6 Miapaca-2 cells) in comparison with RSV or MET alone treatment on day 40. Combination treatment significantly decreased VEGF-B expression and inhibited activity of GSK-3β when compared to the RSV alone treatment. Up-regulated expressions of Bax, cleaved caspase-3 and down-regulated expression of Bcl-2 were observed in RSV+ MET group in comparison with RSV group either in vitro or in vivo . Inhibition of VEGF-B by VEGF-B small interfering RNA (siRNA) mimicked the effects of MET on PaCa cells. These results suggested that MET, a potential pharmacological inhibitor of VEGF-B signaling pathway, potentiated the anti-tumor effect of RSV on PaCa, and combination of MET and RSV would be a promising modality for clinical PaCa therapy.

References

36